Microbial dysbiosis, a new risk factor in colorectal cancer?;Microbiome: Un nouveau facteur de risque de cancer colorectal ?

Medecine/Sciences

Volumn 29, Issue 6-7, 2013, Pages 582-585

  Jobin, Christian ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; COLORECTAL TUMOR; ESCHERICHIA COLI INFECTION; HUMAN; METAGENOME; MICROBIOLOGY; PHYSIOLOGY; RISK FACTOR;

BACTERIAL INFECTIONS; COLORECTAL NEOPLASMS; ESCHERICHIA COLI INFECTIONS; HUMANS; METAGENOME; RISK FACTORS;

EID: 84880851652     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2013296010     Document Type: Article

References (12)

1. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6 : e16393.
2. Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2011; 6 : 320-9.
3. Sanapareddy N, Legge RM, Jovov B, et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J 2012; 6 : 1858-68.
4. Marchesi JR, Dutilh BE, Hall N, et al. Towards the human colorectal cancer microbiome. In: Ahmed N, ed. PLoS One 2011; 6 : e20447.
5. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22 : 292-8.
6. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22 : 299-306.
7. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 2012; 7 : e39743.
8. Strauss J, Kaplan GG, Beck PL, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 2011; 17 : 1971-8.
9. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD: what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012; 9 : 219-30.
10. Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338 : 120-3.
11. Nougayrede JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006 ; 313 : 848-51.
12. Bernardo P, Albina E, Eloit M, Roumagnac P. Métagénomique virale et pathologie, une histoire récente. Med Sci (Paris) 2013; 29 : 501-8.